BioInvent and Transgene and report positive BT-001 data : vi

Tumour treatment among all phase 1a cohorts in were concluded with no safety concerns - News - PharmaTimes

Related Keywords

Martin Welschof , Bioinvent International , Bioinvent , Transgene , T 001 ,